Skip to main content
Log in

Synthesis and cytotoxicity of phenyl-vinyl derivatives of 4,6,6-trimethyl-2-oxo-1,2,5,6-tetrahydropyridine-3-carbonitrile

  • Published:
Chemistry of Heterocyclic Compounds Aims and scope

A series of phenylvinyl derivatives of 4,6,6-trimethyl-2-oxo-1,2,5,6-tetrahydropyridine-3-carbonitriles has been synthesized and their cytotoxic activity towards HT-1080 (human fibrosarcoma) and MG 22A (mouse hepatoma) tumor cells studied. It was found that the 2-nitro-, 2- and 3-chloro, 2-fluoro, and 2-bromophenyl derivatives showed high cytotoxic activity towards both cell lines. The toxicity towards NIH 3T3 normal mouse embryonic fibroblasts depends on the nature and position of the substituent in the phenyl ring. The greatest selectivity of cytotoxic effect was seen in the 2-bromophenyl derivative.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. S. R. Klutchko, J. M. Hamby, D. H. Boschelli, Z. Wu, A. J. Kraker, A. M. Amar, B. G. Hartl, C. Shen, W. D. Klohs, R. W. Steinkampf, D. L. Driscoll, J. M. Nelson, W. L. Elliott, B. J. Roberts, C. L. Stoner, P. W. Vincent, D. J. Dykes, R. L. Panek, G. H. Lu, T. C. Major, T. K. Dahring, H. Hallak, L. A. Bradford, H. D. H. Showalter, and A. M. Doherty, J. Med. Chem., 41, 3276 (1998).

    Article  CAS  Google Scholar 

  2. D. H. Boschelli, Z. Wu, S. R. Klutchko, H. D. H. Showalter, J. M. Hamby, G. H. Lu, T. C. Major, T. K. Dahring, B. Batley, R. L. Panek, J. Keiser, B. G. Hartl, A. J. Kraker, W. D. Klohs, B. J. Roberts, S. Patmore, W. L. Elliott, R. Steinkampf, L. A. Bradford, H. Hallak, and A. M. Doherty, J. Med. Chem., 41, 4365 (1998).

    Article  CAS  Google Scholar 

  3. A. M. Thompson, G. W. Rewcastle, S. L. Boushelle, B. G. Hartl, A. J. Kraker, G. H. Lu, B. L. Batley, R. L. Panek, H. D. H. Showalter, and W. A. Denny, J. Med. Chem., 43, 3134 (2000).

    Article  CAS  Google Scholar 

  4. A. J. Kraker, B. G. Hartl, A. M. Amar, M. R. Barvian, H. D. H. Showalter, and C. W. Moore, Biochem. Pharmacol., 60, 885 (2000).

    Article  CAS  Google Scholar 

  5. A. Gazit, P. Yaish, C. Gilon, and A. Levitzki, J. Med. Chem., 32, 2344 (1989).

    Article  CAS  Google Scholar 

  6. A. Gazit, N. Osherov, I. Posner, P. Yaish, E. Poradosu, C. Gilon, and A. Levitzki, J. Med. Chem., 34, 1896 (1991).

    Article  CAS  Google Scholar 

  7. T. R. Burke, Drugs Fut., 17, 119 (1992).

    Google Scholar 

  8. V. G. Brunton, M. J. Lear, D. J. Robins, S. Williamson, and P. Workman, Anti-Cancer Drug Design, 9, 291 (1994).

    CAS  Google Scholar 

  9. M. Á. Ortega, M. J. Morancho, F. J. Martínez-Crespo, Y. Sainz, M. E. Montoya, A. L. Ceráin, and A. Monge, Eur. J. Med., 35, 21 (2000).

    Article  CAS  Google Scholar 

  10. S. Sirikantaramas, T. Asano, H. Sudo, M. Yamazaki, and K. Saito, Curr. Pharm. Biotechnol., 8, 196 (2007).

    Article  CAS  Google Scholar 

  11. S. O′Keilly and E. K. Rowinsky, Crit. Rev. Oncol. Hematol., 24, 47 (1996).

    Article  Google Scholar 

  12. C. F. Verschraegen, Curr. Opin. Oncol. Endocr. Metab. Invest. Drugs, 1, 184 (1999).

    CAS  Google Scholar 

  13. K. Seiter, Expert Opin. Drug Safety, 4, 45 (2005).

    Article  CAS  Google Scholar 

  14. J. A. Ajani, C. Takimoto, C. R. Becerra, A. Silva, L. Baez, A. Cohn, P. Major, M. Kamida, K. Feit, and R. De Jager, Invest. New Drugs, 23, 479 (2005).

    Article  CAS  Google Scholar 

  15. C. H. Takimoto and R. Thomas, Ann. N. Y. Acad. Sci., 922, 224 (2000).

    Article  CAS  Google Scholar 

  16. E. Lukevics and L. Ignatoviсh, in: M. Gielen and E. R. T. Tiekink (editors), Metallotherapeutic Drugs and Metal-based Diagnostic Agents, John Wiley and Sons Ltd., Chichester (2005), p. 83.

  17. M. Muhsin, C. Gricks, and P. Kirkpatrick, Nature Rev. Drug Discov., 3, 825 (2004).

    Article  CAS  Google Scholar 

  18. Wiley Handbook of Current and Emerging Drug Therapies, Vol. 1, John Wiley and Sons, Ltd., Hoboken, NJ, USA (2007), p. 478.

  19. P. Norman, Curr. Opin. Invest. Drugs, 3, 313 (2002).

    CAS  Google Scholar 

  20. J. C. S. Bergh, T. H. Tötterman, B. C. Termander, K.A.-M.P. Strandgården., P. O. G. Gunnarsson, and B. I. Nilsson, Cancer Invest., 3, 204 (1997).

    Article  Google Scholar 

  21. B. Hartley-Asap, J. Vukanovic, I. B.-J. K. Joseph, K. Strandgården, J. Polacek, and J. T. Isaacs, J. Urol., 158, 902 (1997).

    Article  Google Scholar 

  22. A. J. Bridges, Emerging Drugs, 3, 279 (1998).

    Article  CAS  Google Scholar 

  23. V. Nesterenko, K. S. Putt, and P. J. Hergenrother, J. Am. Chem. Soc., 125, 14672 (2003).

    Article  CAS  Google Scholar 

  24. K. J. O′Byrne and W. P. Steward, Emerging Drugs, 6, 155 (2001).

    Article  Google Scholar 

  25. J. A. Baur and D. A. Sinclair, Nature Rev. Drug Discov., 5, 493 (2006).

    Article  CAS  Google Scholar 

  26. C. K. Osborne, N. Engl. J. Med., 339, 1609 (1998).

    Article  CAS  Google Scholar 

  27. Wiley Handbook of Current and Emerging Drug Therapies, Vol. 1, John Wiley and Sons, Inc., Hoboken, NJ, USA ( 2007), pp. 250, 542.

  28. S. Fortin, E. Moreau, J. Lacroix, J. C. Teulade, A. Patenaude, and R. C. Gaudreault, Bioorg. Med. Chem. Lett., 17, 2000 (2007).

    Article  CAS  Google Scholar 

  29. D. J. Kerr, E. Hamel, M. K. Jung, and B. L. Flynn, Bioorg. Med. Chem., 15, 3290 (2007).

    Article  CAS  Google Scholar 

  30. J. E. Robinson and R. J. K. Taylor, J. Chem. Soc., Chem. Commun., 16, 1617 (2007).

    Google Scholar 

  31. N. J. Lawrence, R. P. Patterson, Li-Ling Ooi, D. Cook, and S. Ducki, Bioorg. Med. Chem. Lett., 16, 5844 (2006).

    Article  CAS  Google Scholar 

  32. F. Bellina, S. Cauteruccio, S. Monti, and R. Ross, Bioorg. Med. Chem. Lett., 16, 5757 (2006).

    Article  CAS  Google Scholar 

  33. Guidance Document on Using in vitro Data to Estimate in vivo Starting Doses for Acute Toxicity, National Institute of Health, US Dept. of Health and Human Services (2001), p. 102; http://www.epa.gov/hpv/pubs/general/nih2001b.pdf

  34. G. Veinberg, M. Vorona, I. Shestakova, I. Kanepe, O. Zharkova, R. Mezapuke, I. Turovskis, I. Kalvinsh, and E. Lukevics, Bioorg. Med. Chem., 8, 1033 (2000).

    Article  CAS  Google Scholar 

  35. D. Jansone, M. Fleisher, G. Andreeva, L. Leite, and E. Lukevics, Khim. Geterotsikl. Soedin., 1863 (2005). [Chem. Heterocycl. Comp., 41, 1537 (2005)].

    Google Scholar 

  36. E. Lukevics, L. Ignatovich, I. Sleiksha, V. Muravenko, I. Shestakova, S. Belyakov, and J. Popelis, Appl. Organomet. Chem., 20, 454 (2006).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Jansone.

Additional information

Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 10, pp. 1529-1538, October, 2009.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lukevics, E., Jansone, D., Leite, L. et al. Synthesis and cytotoxicity of phenyl-vinyl derivatives of 4,6,6-trimethyl-2-oxo-1,2,5,6-tetrahydropyridine-3-carbonitrile. Chem Heterocycl Comp 45, 1226–1234 (2009). https://doi.org/10.1007/s10593-010-0411-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10593-010-0411-7

Keywords

Navigation